Sarah E. Strandjord

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

N K Cheung, Hillard M. Lazarus, Floro Miraldi et al. · Journal of Clinical Oncology · 1987 · 412 citations

Immunology, Pathology, Malignant Melanoma +17

Avoidant/Restrictive Food Intake Disorder: Illness and Hospital Course in Patients Hospitalized for Nutritional Insufficiency

Sarah E. Strandjord, Erin H. Sieke, Miranda Richmond et al. · Journal of Adolescent Health · 2015 · 195 citations

Obesity, Nutrition, Clinical Nutrition +8

Cerebellar toxicity with high-dose cytosine arabinoside.

R H Herzig, John Hines, Geoffrey P. Herzig et al. · Journal of Clinical Oncology · 1987 · 164 citations

Cell Death, Pathology, Pharmacotherapy +16

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.

Hillard M. Lazarus, R H Herzig, John Graham‐Pole et al. · Journal of Clinical Oncology · 1983 · 150 citations

Immunohematology, Cell Therapy, Melphalan Therapy +23

Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.

Anne Kessinger, David M. Smith, Sarah E. Strandjord et al. · PubMed · 1989 · 146 citations